Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and ...

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

A single-center U.S. study found relatively little genetic testing is being done for girls with a 50% risk of being a carrier ...

Hemophilia disease is a rare inherited bleeding disorder. People with this genetic condition do not produce sufficient clotting factors, which can cause uncontrolled external or internal bleeding.

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In the spring of 2024, the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later ...

China recently approved its first gene therapy for the rare genetic disorder hemophilia B, drawing renewed attention to this often-overlooked condition. Hemophilia is a rare but serious inherited ...

India has launched its first human gene therapy for hemophilia, showing progress in biotech-led healthcare innovation.

About Hemophilia A Hemophilia A is the most common ... 7.4 billion proteins and has the potential to target any type of genetic mutation across the entire human genome. The Company’s innovative ...